Africa News Ledger
SEE OTHER BRANDS

The most trusted news from Africa

Africa News Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Ledger.

Press releases published on May 23, 2025

Bank Indonesia’s Rate Cut Strategy: Navigating Growth, Stability, and BRICS Realities - EBC Financial Group Analyses

Bank Indonesia’s Rate Cut Strategy: Navigating Growth, Stability, and BRICS Realities - EBC Financial Group Analyses

EBC Financial Group unpacks BI’s 25 bps cut to 5.50%—weighing fiscal stimulus against rupiah risks and the geopolitical opportunities of BRICS membership JAKARTA, INDONESIA, May 23, 2025 /⁨EINPresswire.com⁩/ -- Bank Indonesia (BI) has lowered its …

Imperial Announces Normal Course Issuer Bid

Imperial Announces Normal Course Issuer Bid

VANCOUVER, British Columbia, May 23, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial” or the “Company”) (TSX:III) announces the Toronto Stock Exchange (the “TSX”) has accepted the Company’s Notice of Intention to make a Normal Course Issuer …

Massive Antimony Bearing Stibnite Reported in Bald Hill Drill Holes

Massive Antimony Bearing Stibnite Reported in Bald Hill Drill Holes

ROUYN-NORANDA, Quebec, May 23, 2025 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (GMX – Toronto Stock Exchange, G1MN – Frankfurt, Stuttgart, Berlin, Munich, Tradegate, Lang …

Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas

Invivyd Announces Inclusion of PEMGARDA® (pemivibart) in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for B-Cell Lymphomas

WALTHAM, Mass., May 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), today announced that PEMGARDA® (pemivibart), its investigational monoclonal antibody, has been added to the National Comprehensive Cancer Network® (NCCN®) Clinical Practice …

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., May 23, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new data from several studies of compounds discovered by HUTCHMED including savolitinib, …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service